Selective transduction of protease-rich tumors by matrix-metalloproteinase-targeted retroviral vectors

Gene Therapy

Volumn 6, Issue 9, 1999, Pages 1552-1557

  Peng, K W ^a   Vile, R G ^a   Cosset, F L ^b   Russell, S J ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITÉ DE LYON   (France)

Author keywords

In vivo gene delivery; Matrix metalloproteinase; Targeted retroviral vector

Indexed keywords

MATRIX METALLOPROTEINASE; POLYPEPTIDE; PROTEINASE; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN; VIRUS VECTOR;

ANIMAL EXPERIMENT; ARTICLE; CELL POPULATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME SPECIFICITY; ENZYME SUBSTRATE COMPLEX; GENE TARGETING; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; RETROVIRUS INFECTION; TUMOR; TUMOR XENOGRAFT;

ENDOPEPTIDASES; GENE EXPRESSION; GENE TARGETING; GENE TRANSFER TECHNIQUES; GENETIC ENGINEERING; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; IMMUNOBLOTTING; LUMINESCENT PROTEINS; MATRIX METALLOPROTEINASES; RETROVIRIDAE; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

ANIMALIA; UNIDENTIFIED RETROVIRUS;

EID: 0032846999     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300982     Document Type: Article

References (33)

1. Cosset FL, Russel SJ. Targeting retrovirus entry. Gene Therapy 1996; 3: 946-956.
2. Kasahara N, Dozy AM, Kan YW. Tissue-specific targeting of retroviral vectors through ligand-receptor interactions. Science 1994; 266: 1373-1376.
3. Somia NV, Zoppe M, Verma IM. Generation of targeted retroviral vectors by using single-chain variable fragment: an approach to in vivo gene delivery. Proc Natl Acad Sci USA 1995; 92: 7570-7574.
4. Ager S et al. Retroviral display of antibody fragments: interdomain spacing strongly influences vector infectivity. Hum Gene Ther 1996; 7: 2157-2164.
5. Hall FL et al. Targeting retroviral vectors to vascular lesions by genetic engineering of the MoMLV gp70 envelope protein. Hum Gene Ther 1997; 8: 2183-2192.
6. Chu TH, Dornburg R. Toward highly efficient cell-type-specific gene transfer with retroviral vectors displaying single-chain antibodies. J Virol 1997; 71: 720-725.
7. Pinter A et al. Localization of the labile disulfide bond between SU and TM of the murine leukemia virus envelope protein complex to a highly conserved CWLC motif in SU that resembless the active-site sequence of thiol-disulfide exchange enzymes. J Virol 1997; 71: 8073-8077.
8. Fass D, Harrison SC, Kim PS. Retrovirus envelope domain at 1.7 Å resolution. Nat Struct Biol 1996; 3: 465-469.
9. Fass D et al. Structure of a murine leukemia virus receptor-binding glycoprotein at 2.0 angstrom resolution. Science 1997; 277: 1662-1666.
10. Cosset F-L et al. Retroviral retargeting by envelopes expressing an N-terminal binding domain. J Virol 1995; 69: 6314-6322.
11. Nilson BHK, Morling FJ, Cosset F-L, Russell SJ. Targeting of retroviral vectors through protease-substrate interactions. Gene Therapy 1996; 3: 280-286.
12. Peng KW et al. A gene delivery system activatable by disease-associated matrix metalloproteinases. Hum Gene Ther 1997; 8: 729-738.
13. Fielding AK et al. Inverse targeting of retroviral vectors: selective gene transfer in a mixed population of hematopoietic and nonhematopoietic cells. Blood 1998; 91: 1802-1809.
14. Peng KW, Morling FJ, Cosset F-L, Russell SJ. A retroviral gene delivery system activatable by plasmin. Tumor Targeting 1998; 3: 112-120.
15. Chaclwock MP, Morling FJ, Cosset F-L, Russell SJ. Modification of retroviral tropism by display of IGF-I. J Mol Biol 1999; 285: 485-494.
16. Morling FJ, Peng KW, Cosset F-L, Russel SJ. Masking of retroviral envelope functions by oligomerizing polypeptide adaptors. Virology 1997; 234: 51-61.
17. Buchholz CJ et al. In vivo selection of protease cleavage sites from retrovirus display libraries. Nat Biotech 1998; 16: 951-954.
18. Okada A et al. Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. Proc Natl Acad Sci USA 1995; 92: 2730-2734.
19. Murphy G et al. Regulation of matrix metalloproteinase activity. Ann NY Acad Sci 1994; 732: 31-41.
20. Ray JM, Stetler-Stevenson WG. The role of matrix metalloproteases and their inhibitors in tumor invasion, metasasis and angiogenesis. Eur Resp J 1994; 7: 2062-2072.
21. Edwards DR, Murphy G. Proteases-invasion and more. Nature 1998; 394: 527-528.
22. Duffy MJ. Proteases as prognostic markers in cancer. Clin Cancer Res 1996; 2: 613-618.
23. Ray JM, Stetler-Stevenson WG. Gelatinase A activity directly modulates melanoma cell adhesion and spreading. EMBO J 1995; 14: 908-917.
24. Hooper NM, Karran EH, Turner AJ. Membrane protein secretases. Biochem J 1997; 321: 265-279.
25. Derian CK, Eckardt AJ, Andrade-Gordon P. Differential regulation of human keratinocyte growth and differentiation by a novel family of protease-activated receptors. Cell Growth Differ 1997; 8: 743-749.
26. Springett GM et al. Infection efficiency of T-lymphocytes with amphotropic retroviral vectors in cell cycle dependent. J Virol 1989; 63: 3865-3869.
27. Naldini L et al. Efficient transfer, integration and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci USA 1996; 93: 11382-11388.
28. + lymphoid cells. Gene Therapy 1998; 5: 209-217.
29. Poeschla EM, Wong-Staal F, Looney DJ. Efficient transduction of non-dividing human cells by feline immunodeficiency virus lentiviral vectors. Nature Med 1998; 4: 354-357.
30. Karpusas M et al. 2 Å crystal structure of an extracellular fragment of human CD40 ligand. Structure 1995; 3: 1031-1039.
31. Takeuchi Y et al. Type C retrovirus inactivation by human complement is determined by both the viral genome and producer cell. J Virol 1994; 68: 8001-8007.
32. Cosset F-L et al. High-titer packaging cells producing recombinant retroviruses resistant to human serum. J Virol 1995; 69: 7430-7436.
33. Morling FJ, Russel SJ. Enhanced transduction efficiency of retroviral vectors coprecipitated with calcium phosphate. Gene Therapy 1995; 2: 504-508.